Ocugen Inc. stock rises 1.20 percent and outperforms broader market

8 articles · Updated · MarketWatch · Apr 29

Ocugen Inc. shares closed at $1.68 on Wednesday, up 1.20%, while the S&P 500 and Dow Jones both declined.
Despite the gain, Ocugen remains 38.35% below its 52-week high of $2.73 set on March 17th.
Trading volume was 3.6 million, significantly below the 50-day average of 8.8 million, reflecting subdued investor activity.

Despite a daily gain, is Ocugen's low trading volume a hidden warning sign for the stock?

Why do analysts predict an $8 price for Ocugen when it currently trades under $2?

With cash lasting only until Q4 2026, how will Ocugen fund its path to drug approval?

Ocugen’s retinal therapy shows promise, but when could it realistically be available to patients?

Could OCU400 become the first therapy to revolutionize treatment for most Retinitis Pigmentosa patients?